New Appointment to the Scientific Advisory Committee at Egenix, Inc. - KTEN.com - No One Gets You Closer

New Appointment to the Scientific Advisory Committee at Egenix, Inc.

  • Texoma HeadlinesMore>>

  • Chickasaw Nation Opens Community Center In Ardmore

    Chickasaw Nation Opens Community Center In Ardmore

    ARDMORE, OK -- The Chickasaw Nation opened a new addition to it's Carter service campus in Ardmore Wednesday morning. With a snip of the ribbon, the the newest addition to the Chickasaw Carter service center officially opened.More >>
    ARDMORE, OK -- The Chickasaw Nation opened a new addition to it's Carter service campus in Ardmore Wednesday morning. With a snip of the ribbon, the the newest addition to the Chickasaw Carter service center officially opened.
    More >>
  • Woman Arrested For Hitting Two With Brick

    Woman Arrested For Hitting Two With Brick

    ARDMORE, OK -- Ardmore police arrested a local woman after they say she hit two different people in the head with a brick. Officers arrested 40-year old Daphne Morales of Ardmore on charges of assault with a deadly weapon and public intoxication.More >>
    ARDMORE, OK -- Ardmore police arrested a local woman after they say she hit two different people in the head with a brick. Officers arrested 40-year old Daphne Morales of Ardmore on charges of assault with a deadly weapon and public intoxication.
    More >>
  • Second Annual Ardmore Community Forum

    Second Annual Ardmore Community Forum

    ARDMORE, OK -- City officials gathered at the convention center in Ardmore for their second annual community forum. Organizers of the forum say more than 200 people attended.More >>
    ARDMORE, OK -- City officials gathered at the convention center in Ardmore for their second annual community forum. Organizers of the forum say more than 200 people attended.
    More >>

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Egenix, Inc.

MILLBROOK, N.Y., May 16, 2014 /PRNewswire/ -- Donald Fresne, President and CEO of Egenix, Inc. is pleased to announce the appointment of Hans-Guido Wendel, MD, to its Scientific Advisory Committee.

Dr. Wendel, a graduate of the University of Aachen, Germany, trained in clinical hemato-oncology in Germany, performed research at Cold Spring Harbor and presently holds a tenure-track position at Sloan Kettering Institute NYC focusing on the genetics of lymphatic cancer and initially identified oncogenic role of the eIF4E translation factor in that cancer.

We at Egenix are delighted to have Dr. Wendel aboard and feel confident that he will make significant contributions to Egenix and to the advancement of science and medicine.

Egenix is a privately held, New York-based biotechnology company focused on the development of innovative cancer therapeutics. The company's therapeutic platform technology consists of small molecule drugs applicable for the treatment and prevention of a broad spectrum of cancers, autism, and Alzheimer's. Our lead drug candidates inhibit the "translation initiation factor" eIF4E, specifically blocking production of multiple cancer promoting proteins and promoting apoptosis (programmed cell death) and upregulation of tumor suppressor genes. The company licensed this technology from Harvard Medical School in 2007. eIF4E is an attractive cancer therapeutic target because every function necessary for cancer growth and metastasis is influenced or mediated be a gene product that is regulated by this translation initiation factor. Data from human cancer xenograft studies using two of our lead compounds tested against breast cancer and melanoma demonstrated 100% tumor inhibition and 20% to 30% tumor reduction. For more information visit www.egenixinc.com

©2012 PR Newswire. All Rights Reserved.